title: Enalapril acts through release of nitric oxide in patients with essential hypertension.
abstract: BACKGROUND
  Endothelial dysfunction has been proposed as an etiological agent in the pathogenesis of essential hypertension. Amongst the various antihypertensive drugs, angiotensin converting enzyme inhibitors (ACEI) have been implicated in modifying the vascular endothelium by the release of mediators that include bradykinin, nitric oxide, prostaglandins and thromboxane A2.
  
  
  METHODS
  To study the mechanism of action of enalapril, an ACEI, serum reactive nitrite intermediates (RNI) and citrulline, by products of nitric oxide metabolism were measured before and after treatment with enalapril in 25 consecutive patients of essential hypertension.
  
  
  RESULTS
  Following treatment serum RNI intermediate increased from a pretreatment value of 164.5 +/- 20.2 nmol/mL to a post treatment value of 266.9 +/- 47.3 nmol/mL (p < 0.05), however there was no significant change in the levels of citrulline (p > 0.1). There was no significant correlation between the severity of hypertension and serum RNI. Serum RNI levels were lower in the postmenopausal women but did not reach statistical significance.
  
  
  CONCLUSIONS
  It is postulated that enalapril exhibits its antihypertensive property through release of nitric oxide.
authors.affiliation: Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. drsjain@glide.net.in
authors.forename: S
authors.initials: S
authors.lastname: Jain
authors.forename: J
authors.initials: J
authors.lastname: Rajeshwari
authors.forename: M
authors.initials: M
authors.lastname: Khullar
authors.forename: S
authors.initials: S
authors.lastname: Kumari
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D004656:Enalapril / Q000008:administration & dosage*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy*; D007194:India; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000032:analysis / Q000096:biosynthesis*; D011336:Probability; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D009569:Nitric Oxide; D004656:Enalapril